Multiple factors predict physical performance in people with chronic liver disease

American Journal of Physical Medicine and Rehabilitation

Volumn 93, Issue 6, 2014, Pages 470-476

  Loria, Anthony ^a   Doyle, Katherine ^a,b   Weinstein, Ali A ^b   Winter, Patrice ^a,b   Escheik, Carey ^a,c   Price, Jillian ^a,b   Wang, Lei ^b   Birerdinc, Aybike ^a,b   Baranova, Ancha ^a,b   Gerber, Lynn ^a,b,c   Younossi, Zobair M ^a,b,c  

^a BETTY AND GUY BEATTY CENTER FOR INTEGRATED RESEARCH   (United States)

^b GEORGE MASON UNIVERSITY   (United States)

^c INOVA FAIRFAX HOSPITAL   (United States)

Author keywords

6MWT; Chronic Liver Disease; Hepatitis C; NAFLD; QOL

Indexed keywords

INTERLEUKIN 8;

AGE; ARTICLE; BLOOD; EXERCISE TEST; FATTY LIVER; FEMALE; FITNESS; GLUCOSE BLOOD LEVEL; HEART RATE; HEPATITIS C; HUMAN; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; PROSPECTIVE STUDY; REGRESSION ANALYSIS; REST; SEX DIFFERENCE; WALKING;

AGE FACTORS; BLOOD GLUCOSE; EXERCISE TEST; FATTY LIVER; FEMALE; HEART RATE; HEPATITIS C, CHRONIC; HUMANS; INTERLEUKIN-8; MALE; MIDDLE AGED; PHYSICAL FITNESS; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; REST; SEX FACTORS; WALKING;

EID: 84901628185     PISSN: 08949115     EISSN: 15377385     Source Type: Journal    
DOI: 10.1097/PHM.0000000000000050     Document Type: Article

References (54)

1. Lonardo A, Ballestri S, Adinolfi LE, et al: Hepatitis C virus-infected patients are Fspared- from the metabolic syndrome but not from insulin resistance. A comparative study of nonalcoholic fatty liver disease and hepatitis C virusYrelated steatosis. Can J Gastroenterol 2009;23:273-8
2. Armstrong GL, Wasley A, Simard EP, et al: The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann Intern Med 2006; 144:705-14 (Pubitemid 46780630)
3. Bugianesi E, Salamone F, Negro F: The interaction of metabolic factors with HCV infection: Does it matter? J Hepatol 2012;56(suppl 1):S56-65
4. Younossi ZM, McCullough AJ: Metabolic syndrome, non-alcoholic fatty liver disease and hepatitis C virus: Impact on disease progression and treatment response. Liver Int 2009;29:617
5. Ware JE, Bayliss MS, Mannocchia M, et al: for the International Hepatitis Interventional Therapy Group: Health-related quality of life in chronic hepatitis C: Impact of disease and treatment response. Hepatology 1999;30:550-5 (Pubitemid 29357524)
6. Gerber L, Otgonsuren M, Mishra A, et al: Nonalcoholic fatty liver disease (NAFLD) is associated with low level of physical activity. Aliment Pharmacol Ther 2012;36:772-81
7. Price JK, Srivastava R, Bai CH, et al: Comparison of activity level among patients with chronic liver disease. Disabil Rehabil 2013;35:907-12
8. Elliott C, Frith J, Day CP, et al: Functional impairment in alcoholic liver disease and non-alcoholic fatty liver disease is significant and persists over 3 years of follow-up. Dig Dis Sci 2013;58:2383-91
9. Newton JL, Jones DE, Henderson E, et al: Fatigue in non-alcoholic fatty liver disease (NAFLD) is significant and associates with inactivity and excessive daytime sleepiness but not with liver disease severity or insulin resistance. Gut 2008;57:807-13 (Pubitemid 351716975)
10. Newton JL, Pairman J, Wilton K, et al: Fatigue and autonomic dysfunction in non-alcoholic fatty liver disease. Clin Auton Res 2009;19:319-26
11. Benito de Valle M, Rahman M, Lindkvist B, et al: Factors that reduce health-related quality of life in patients with primary sclerosing cholangitis. Clin Gastroenterol Hepatol 2012;10:769-75
12. Cella D, Kallich J, McDermott A, et al: The longitudinal relationship of hemoglobin, fatigue and quality of life in anemic cancer patients: Results from five randomized clinical trials. Ann Oncol 2004;15:979-86 (Pubitemid 39004357)
13. Yimmon A, Zimran A, Hershko C: Quality of life and survival following intensive medical care. Q J Med 1989;71:347-57 (Pubitemid 19142561)
14. Abbott J, Hart A: Measuring and reporting quality of life outcomes in clinical trials in cystic fibrosis: a critical review. Health Qual Life Outcomes 2005;3:19
15. Verghese J, Holtzer R, Oh-Park M, et al: Inflammatory markers and gait speed decline in older adults. J Gerontol A Biol Sci Med Sci 2011;66:1083-9
16. Gupta SC, Kin JH, Kannappan R, et al: Role of nuclear factor kB-mediated inflammatory pathways in cancer-related symptoms and their regulation by nutritional agents. Exp Biol Med 2011;236:658-71
17. Peake JM, Suzuki K, Coombes JS: The influence of antioxidant supplementation on markers of inflammation and the relationship to oxidative stress after exercise. J Nutr Biochem 2007;18:357-71 (Pubitemid 46727043)
18. Beyer I, Njemini R, Bautmans I, et al: Inflammationrelated muscle weakness and fatigue in geriatric patients. Exp Gerontol 2012;47:52-9
19. Maes M, Twisk FN, Kubera M, et al: Evidence for inflammation and activation of cell-mediated immunity in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): Increased interleukin-1, tumor necrosis factor->, PMN-elastase, lysozyme and neopterin. J Affect Disord 2012;136:933-9
20. Meyers CA, Albitar M, Estey E: Cognitive impairment, fatigue, and cytokine levels in patients with acute myelogenous leukemia or myelodysplastic syndrome. Cancer 2005;104:788-93 (Pubitemid 41113679)
21. Collado-Hidalgo A, Bower JE, Ganz PA, et al: Inflammatory biomarkers for persistent fatigue in breast cancer survivors. Clin Cancer Res 2006;12:2759-66
22. Jarrar MH, Baranova A, Collantes R, et al: Adipokines and cytokines in non-alcoholic fatty liver disease. Aliment Pharmacol Ther 2008;27:412-21
23. Younossi ZM, Kallman J, Kincaid J: The effects of HCV infection and management on health-related quality of life. Hepatology 2007;45:806-16 (Pubitemid 46450632)
24. Younossi ZM, Stepanova M, Afendy M, et al: Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988-2008. Clin Gastroenterol Hepatol 2011;9: 524-30
25. Jacobson IM, Cacoub P, Dal Maso L, et al: Manifestations of chronic hepatitis C virus infection beyond the liver. Clin Gastroenterol Hepatol 2010;8:1017-29
26. Newton JL, Jones DE: Making sense of fatigue. Occup Med (Lond) 2010;60:326-9
27. Guyatt GH, Sullivan MJ, Thompson PJ, et al: The 6-minute walk: A new measure of exercise capacity in patients with chronic heart failure. Can Med Assoc J 1985;132:919-23
28. Butland RJ, Pang J, Gross ER, et al: Two-, six-, and 12-minute walking tests in respiratory disease. Br Med J (Clin Res Ed) 1982;285:1607-8 (Pubitemid 12105148)
29. Juenger J, Schellberg D, Kraemer S, et al: Health related quality of life in patients with congestive heart failure: comparison with other chronic diseases and relation to functional variables. Heart 2002;87: 235-41 (Pubitemid 34177677)
30. Trudeau SA: Enhanced ambulation and quality of life in advanced Alzheimer's disease. J Am Geriatr Soc 2003;51:429-31 (Pubitemid 36348911)
31. Bocalini DS, dos Santos L, Serra AJ: Physical exercise improves the functional capacity and quality of life in patients with heart failure. Clinics (Sao Paulo) 2008; 63:437-42
32. Alameri HF, Sanai FM, Al Dukhayil M, et al: Six Minute Walk Test to assess functional capacity in chronic liver disease patients. World J Gastroenterol 2007;13:3996-4001 (Pubitemid 47272499)
33. Bittner V, Weiner DH, Yusuf S, et al: Prediction of mortality and morbidity with a 6-minute walk test in patients with left ventricular dysfunction. SOLVD Invesigators. JAMA 1993;270:1702-7 (Pubitemid 23295315)
34. Paciocco G, Martinez FJ, Bossone E, et al: Oxygen desaturation on the six-minute walk test and mortality in untreated primary pulmonary hypertension. Eur Respir J 2001;17:647-52 (Pubitemid 32492552)
35. Carey EJ, Steidley DE, Aqel BA, et al: Six-minute walk distance predicts mortality in liver transplant candidates. Liver Transpl 2010;16:1337-78
36. Motl RW, Balantrapu S, Pilutti L, et al: Symptomatic correlates of six-minute walk performance in persons with multiple sclerosis. Eur J Phys Rehabil Med 2013; 49:59-66
37. Merritta C, Cherian B, Macaden AS, et al: Measurement of physical performance and objective fatigability in people with mild-to-moderate traumatic brain injury. Int J Rehabil Res 2010;33:109-14
38. Baughman RP, Sparkman BK, Lower EE: Six-minute walk test and health status assessment in sarcoidosis. Chest 2007;132:207-13 (Pubitemid 47068223)
39. Garcia-Juarez I, Chavez-Ayala A, Duarte-Rojo A, et al: Six minute walk test as a predictor of survival in cirrhosis. Liver Meeting 2010;52(suppl):920A
40. Lederer DJ, Arcasoy SM, Wilt JS, et al: Six minute walk distances predicts waiting list survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2006;174:659-64 (Pubitemid 44395333)
41. Boxer R, Kleppinger A, AAhmad A, et al: The 6- minute walk is associated with frailty and predicts mortality in older adults with heart failure. Congest Heart Fail 2010;16:208-13
42. Mutikainen S, Rantanen T, Alén M, et al: Walking ability and all-cause mortality in older women. Int J Sports Med 2011;32:216-22
43. Strauss E, Dias Teixeira MC: Quality of life in hepatitis C. Liver Int 2006;26:755-65 (Pubitemid 44165242)
44. Abdo AA: Hepatitis C and poor quality of life: Is it the virus or the patient? Saudi J Gastroenterol 2008;14:109-13
45. Spiegel BM, Younossi ZM, Hays RD, et al: Impact of hepatitis C on health related quality of life: A systematic review and quantitative assessment. Hepatology 2005;41:790-800 (Pubitemid 40462941)
46. Kallman J, O'Neil MM, Larive B, et al: Fatigue and health-related quality of life (HRQL) in chronic hepatitis C virus infection. Dig Dis Sci 2007;520: 2531-9 (Pubitemid 47373904)
47. Berger AM, Gerber LH, Mayer DK: Cancer-related fatigue: Implications for breast cancer survivors. Cancer 2012;118(suppl):2261-9. doi:10.1002/cncr.27475.
48. Patra SK, Arora S: Integrative role of neuropeptides and cytokines in cancer anorexia-cachexia syndrome. Clin Chim Acta 2012;413:1025-34
49. Nas K, Cevik R, Batum S, et al: Immunologic and psychosocial status in chronic fatigue syndrome. Bratisl Lek Listy 2011;112:208-12
50. Beltran B, Cuadrado C, Martin ML, et al: Activities of daily living in the Spanish elderly. Association with mortality. J Nutr Health Aging 2001;5:259-60
51. ZekryD, Frangos E, Graf C, et al:Diabetes, comorbidities and increased long-term mortality in older patients admitted for geriatric inpatient care. DiabetesMetab 2012; 38:149-55
52. Carbonell-Baeza A, Aparicio VA, Sjostrom M, et al: Pain and functional capacity in female fibromyalgia patients. Pain Med 2011;12:1667-75
53. Elliott C, Newton J: Occupational therapy in chronic liver disease: A gap in service delivery. Br J Occup Ther 2009;72:133-6
54. Nobili V, Carter-Kent C, Feldstein AE: The role of lifestyle changes in the management of chronic liver disease. BMC Med 2011;9:70